临床儿科杂志 ›› 2022, Vol. 40 ›› Issue (4): 306-310.doi: 10.12372/jcp.2022.21e0723

• 罕见病 疑难病 • 上一篇    下一篇

PARS2基因变异致早发性婴儿癫痫性脑病1例报告

王秀英, 田杨(), 石真, 侯池, 李小晶, 朱海霞, 曹彬彬, 陈文雄, 伍湘玲   

  1. 广州市妇女儿童医疗中心神经内科(广东广州 510000)
  • 收稿日期:2021-05-17 出版日期:2022-04-15 发布日期:2022-04-07
  • 通讯作者: 田杨 E-mail:948938756@qq.com

Early infantile-onset epileptic encephalopathy caused by PARS2 gene variation: a case report

WANG Xiuying, TIAN Yang(), SHI Zhen, HOU Chi, LI Xiaojing, ZHU Haixia, CAO Binbin, CHEN Wenxiong, WU Xiangling   

  1. Neurology Department, Guangzhou Women and Children’s Medical Center, Guangzhou 510000, Guangdong, China
  • Received:2021-05-17 Online:2022-04-15 Published:2022-04-07
  • Contact: TIAN Yang E-mail:948938756@qq.com

摘要:

遗传学因素是早发性婴儿癫痫性脑病的常见病因。文章鉴定1例早发性婴儿癫痫性脑病患儿的致病性变异。男性患儿,4月27日龄,反复抽搐发作20余天,表现为痉挛发作,伴发育迟缓。其父母表型无异常。患儿存在PARS2基因c.287G>A(p.Arg96His)和c.283G>A(p.Val95Ile)复合杂合变异,前者来源于母亲,后者来源于父亲。前者未见报道,后者变异c.283G>A既往已有报道,根据美国遗传学和基因组学学会指南判断两者均为“意义未明”。给予患儿托吡酯联合硝基安定口服治疗6周后癫痫发作控制,精神及运动发育显著落后,肌张力低下。研究提示PARS2基因复合杂合突变是此家系中早期婴儿癫痫性脑病患儿的致病性变异,为该家系的遗传咨询提供了基础;即使控制了癫痫发作,PARS2基因变异所致的癫痫性脑病仍具有严重的发育迟滞。

关键词: PARS2基因, 癫痫, 脑病, 婴儿

Abstract:

Genetic factors are common causes of early infantile-onset epileptic encephalopathy. The pathogenicity variation of a child with early infantile-onset epileptic encephalopathy was reported in this paper. The boy was 4 months and 27 days old. He had recurrent convulsions for more than 20 days, characterized by convulsive seizures and developmental retardation. The proband's parents had no abnormal phenotype. The proband had compound heterozygous variation of c.287G>A (p.Arg96His) and c.283G>A (p.Val95Ile) in PARS2 gene. The former was derived from the mother, and the latter from the father. Among them, the former phenotype has not been reported, while the latter variant of C. 283G>A has been reported in the past. According to the guidelines of the American College of Medical Genetics and Genomics, both of them are considered to be of "unknown significance". After 6 weeks of oral treatment with topiramate and nitrazepam, seizure was controlled, but the child still had significant psychomotor developmental retardation and hypotonia. The results suggested that a novel compound heterozygous variation of PARS2 gene is the pathogenic variation of the child with early infantile-onset epileptic encephalopathy in this family, which provides a basis for genetic counseling in this family. Epileptic encephalopathy caused by PARS2 gene variation still has severe developmental retardation even when seizure is controlled.

Key words: PARS2 gene, epilepsy, encephalopathy, infant